Press releases

Boston Scientific will participate in the upcoming investor healthcare conference in May 2019. A live webcast and replay will be available.

"With our strong pipeline and category leadership strategy, we are confident in our top tier 2019 outlook,” said CEO Mike Mahoney. Read the April 2019 release.

Transcatheter aortic valve replacement technology for patients with severe aortic stenosis designed to minimize paravalvular leakage, offer controlled delivery and repositionability post deployment.

The inaccessibility of these products will severely limit treatment options for the 50% of women in the U.S. who will suffer from POP during their lives.

Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2019.

New data showcases safety & efficacy of recently acquired RF balloon-based, single-shot ablation technology when treating patients with AFib.

Company begins limited market release in Europe for next generation WATCHMAN device, intended to reduce the risk of stroke in people with non-valvular AFib.

Key data to be featured at European Heart Rhythm Association (EHRA) Congress include outcomes from the LUMINIZE RF balloon catheter for the treatment of AFib.

Solutions for nutrition support and early detection of respiratory issues win and place at Connected Patient Challenge competition focused on chronic conditions.

Boston Scientific will participate in the upcoming healthcare conference in February 2019. A live webcast and replay will be available.